Metabolites
Displaying metabolites 401 - 425 of 3755 in total
| Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
|---|---|---|---|---|---|
| ECMDB01399 | 4,6-Dideoxy-4-oxo-dTDP-D-glucose | {[(3R,4R,6R)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl]oxy}({[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid | 546.3137 C16H24N2O15P2 |  | |
| ECMDB24055 | 4-(2-Aminophenyl)-2,4-dioxobutanoic acid | 4-(2-aminophenyl)-2,4-dioxobutanoic acid | 207.1828 C10H9NO4 |  | |
| ECMDB23151 | 4-(2-Carboxyphenyl)-4-oxobutanoyl-CoA | 2-[4-({2-[(3-{[(2R)-4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-(hydrogen phosphonatooxy)-4-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-1-oxidobutylidene]amino}-1-oxidopropylidene)amino]ethyl}sulfanyl)-4-oxobutanoyl]benzoate | 967.681 C32H40N7O20P3S |  | |
| ECMDB20083 | 4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol | [({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R,3S)-2,3,4-trihydroxy-3-methylbutoxy]phosphinic acid | 519.294 C14H23N3O14P2 |  | |
| ECMDB12161 | 4-(Glutamylamino) butanoate 5105-96-4 | (2S)-2-amino-4-[(3-carboxypropyl)carbamoyl]butanoic acid | 232.2337 C9H16N2O5 |  | |
| ECMDB23991 | 4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde | (2E,4Z,6S)-6-amino-2-hydroxy-4-(2-oxoethylidene)hept-2-enedioic acid | 229.188 C9H11NO6 |  | |
| ECMDB24192 | 4-(γ-glutamylamino)butanal | 2-amino-4-[(4-oxobutyl)carbamoyl]butanoate | 215.23 C9H15N2O4 |  | |
| ECMDB20084 | 4-Amino-2-methyl-5-phosphomethylpyrimidine | [(6-imino-2-methyl-1,6-dihydropyrimidin-5-yl)methoxy]phosphonic acid | 217.122 C6H8N3O4P |  | |
| ECMDB23100 | 4-Amino-4-deoxy-alpha-L-arabinopyranosyl di-trans,octa-cis-undecaprenyl phosphate | N-[(3S,4S,5R,6S)-4,5-dihydroxy-6-{[hydroxy({[(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl]oxy})phosphoryl]oxy}oxan-3-yl]carboximidic acid | polymyxin resistance PW002052 | 1006.4224 C61H100NO8P |  |
| ECMDB21497 | 4-Amino-4-deoxy-L-arabinose | [({[(2R,3R,4S,5S)-5-amino-3,4-dihydroxyoxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | One Carbon Pool by Folate I PW001735 | 535.291 C14H23N3O15P2 |  |
| ECMDB21173 | 4-Amino-4-deoxy-L-arabinose modified core oligosaccharide lipid A | 2-{[(3S,4R,5R,6R)-3-({[(5-amino-3,4-dihydroxyoxan-2-yl)oxy](hydroxy)phosphoryl}oxy)-5-{[(3R)-3-(dodecanoyloxy)-1-oxidotetradecylidene]amino}-6-{[(2R,3S,4R,5R)-3-hydroxy-5-{[(3R)-3-hydroxy-1-oxidotetradecylidene]amino}-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-6-(phosphonooxy)oxan-2-yl]methoxy}-4-{[(3R)-3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}-4-[(2-carboxylato-4-{[2-carboxylato-6-(1,2-dihydroxyethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-(1,2-dihydroxyethyl)-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl)oxy]-6-(1,2-dihydroxyethyl)-5-{[6-(1,2-dihydroxyethyl)-4-{[6-(2-{[6-(1,2-dihydroxyethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxyethyl)-4-({4-[(3-{[6-({[6-(1,2-dihydroxyethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-3,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl}oxy)-3-hydroxy-5-(phosphonatooxy)oxan-2-yl]oxy}-3-hydroxy-5-(phosphonatooxy)oxan-2-yl]oxy}oxane-2-carboxylate | 4304.2832 C181H314N3O103P4 |  | |
| ECMDB20085 | 4-Amino-4-deoxychorismate 133442-18-9 | (3R,4R)-4-amino-3-[(1-carboxyeth-1-en-1-yl)oxy]cyclohexa-1,5-diene-1-carboxylic acid | Folate biosynthesis PW000908 | 224.193 C10H10NO5 |  |
| ECMDB20086 | 4-Amino-5-hydroxymethyl-2-methylpyrimidine 73-67-6 | (4-amino-2-methylpyrimidin-5-yl)methanol | 139.1552 C6H9N3O |  | |
| ECMDB23090 | 4-amino-5-phosphonooxymethyl-2-methylpyrimidine | [(6-imino-2-methyl-1,6-dihydropyrimidin-5-yl)methoxy]phosphonic acid | 219.1351 C6H10N3O4P |  | |
| ECMDB01080 | 4-Aminobutyraldehyde 4390-05-0 | 4-aminobutanal | 87.1204 C4H9NO |  | |
| ECMDB20087 | 4-Carboxy-4-hydroxy-2-oxoadipate | 2-hydroxy-4-oxobutane-1,2,4-tricarboxylic acid | 220.1336 C7H8O8 |  | |
| ECMDB24241 | 4-deoxy-4-formamido-α-L-arabinopyranosyl ditrans,octacis-undecaprenyl phosphate | [(5-formamido-3,4-dihydroxyoxan-2-yl)oxy]({[(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl]oxy})phosphinic acid | 1006.444 C61H100NO8P |  | |
| ECMDB21420 | 4-Deoxyerythronic acid 759-06-8 | (2R,3R)-2,3-dihydroxybutanoic acid | 120.1039 C4H8O4 |  | |
| ECMDB20088 | 4-Glutathionyl cyclophosphamide | 2-amino-4-{[2-({2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2λ⁵-oxazaphosphinan-4-yl}sulfanyl)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid | 566.394 C17H30Cl2N5O8PS |  | |
| ECMDB02070 | 4-Hydroxy-2-oxoglutaric acid | 2-hydroxy-4-oxopentanedioic acid | 162.0975 C5H6O6 |  | |
| ECMDB20089 | 4-Hydroxy-2-oxohexanoic acid | 4-hydroxy-2-oxohexanoic acid | Collection of Reactions without pathways PW001891 | 146.1412 C6H10O4 |  |
| ECMDB20090 | 4-Hydroxy-2-oxopentanoate 3318-73-8 | 4-hydroxy-2-oxopentanoic acid | 131.108 C5H7O4 |  | |
| ECMDB23756 | 4-Hydroxy-3-polyprenylbenzoate | 3-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxybenzoic acid | 274.3548 C17H22O3 |  | |
| ECMDB20091 | 4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one | 5-phenyl-5,6-dihydro-4H-1,3-oxazine-2,4-diol | 193.1992 C10H11NO3 |  | |
| ECMDB24088 | 4-Hydroxy-L-proline | (2S)-4-hydroxypyrrolidine-2-carboxylic acid | 131.1299 C5H9NO3 |  |